Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
326.40    -9.00 (-2.68%)
Bid:
326.60
Ask:
327.40
Spread: 0.80 (0.245%)
Market Cap: £715.04m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Trading Update

30 Jun 2011 07:00

RNS Number : 4114J
Burford Capital
30 June 2011
 

t

 

 

 

30 June 2011

Burford Capital Announces Continued Investment Progress

 

Burford Capital Limited ("Burford" or the "Company"), the world's largest dispute financier, is pleased to report on its further progress since the Company's previous update on 23 March 2011.

Investment Highlights

·; More than $165 million of capital committed to date in 29 investments

o More than $26 million in new capital commitments across four investments made in the last three months

·; Short duration portfolio continues to progress since our last report

o There has been a favorable resolution of the litigation in a short duration matter. That resolution removes litigation risk from the investment, although Burford's counterparty has not yet received any proceeds and thus timing and collection risk remains. Burford's $6 million investment in this matter, made in September 2010, entitles the Company to a return of at least 50% today, with that return rising over time until Burford receives proceeds.

o Two arbitration matters have completed their final merits hearings and are awaiting decision.

o One litigation matter has a firm trial date next month.

o Thus, of the eight matters currently in the short duration portfolio - in addition to two prior matters that have been fully resolved and proceeds received - the status is as follows:

§ Favorable resolutions, awaiting funds: 2 matters

§ Positive trial result: 1 matter

§ Positive appeal result: 1 matter

§ Merits hearing completed, awaiting decision: 1 matter

§ Trial date next month: 1 matter

§ Litigation continuing: 1 matter

§ Previously identified as likely to disappoint: 1 matter

 

 

Portfolio Information

Burford's current investment portfolio is as shown in the table below. 1

 

Portfolio Type

Total Investments

Total Capital Committed2

Short duration

8

$38 million

Core

16

$96 million

Special Situations

3

$21 million3

 

Burford continues to see strong demand for its capital with an active pipeline of potential investments of widely varying size and duration.

Additions to Burford Group's Team

Burford Group, the Company's investment adviser, has recently announced a further addition to its industry-leading team. Joseph Cheavens, a highly experienced litigator, former Chairman of the Baker Botts litigation department and member of the firm's Executive Committee, has joined Burford Group to focus on the Texas market. Baker Botts is a Texas institution, founded there in 1840; it has since expanded to be a leading international law firm with 725 lawyers around the world.

Industry Developments

Litigation finance continues to receive significant media attention in both the United Kingdom and the United States. The Company was pleased to note that the prestigious New York City Bar Association, in response to the ongoing media attention, undertook its own study of litigation finance and concluded that "non-recourse litigation financing is on the rise, and provides to some claimants a valuable means for paying the costs of pursuing a legal claim" and that it is "not unethical" for lawyers to be involved in litigation financing arrangements. Reuters described the development as: "New York City Bar gives thumbs up to litigation funding".

Annual Report

Pursuant to AIM Rule 20, the Company advises that it has sent the Company's Annual Report for the year ended 31 December 2010 to shareholders. The report may also be viewed on the Company's website at www.burfordcapital.com.

Semi-Annual Report and Investment Update

The Company anticipates releasing its results as at 30 June 2011 in early September. At the same time, the Company will provide a further update on its investment activities covering the period up until the date of that release, as is its usual custom.

The Company notes that law firms tend to be less focused on closing investments in the summer and as a result anticipates lower than normal investment activity in its next report given both the short reporting period and the summer months. Nevertheless, the Company has a robust pipeline of investment opportunities and reaffirms its prior guidance about its intention to deploy its total capital raised by mid-2012.

 

Christopher Bogart, Chief Executive Officer of Burford Group, commented: 

"We are very pleased with where Burford stands today. We provide investors with market-leading portfolio diversification and a strong team, the results of which are showing themselves both in our continued deployment of capital and ongoing performance of the portfolio."

For further information, please contact:

Macquarie Capital (Europe) Limited

Jonny Franklin-Adams +44 (0)20 3037 5231

Steve Baldwin +44 (0)20 3037 2147

 

Espirito Santo Investment Bank

Richard Crawley +44 (0) 20 7456 9191

Financial Dynamics

Edward Berry +44 (0)20 7269 7297

Laura Pope +44 (0) 20 7269 7243

www.burfordcapital.com

About Burford Capital

Burford Capital's strategy is to create and manage a portfolio of commercial dispute financing investments diversified by duration, claim type, geography and a number of other variables, with the aim of providing shareholders with attractive levels of dividends and capital growth. The Company expects returns to be uncorrelated to general equity market performance.

In the short term, the Company's focus is on commercial disputes in the United States and on international arbitration matters; in the medium term, the Company may expand its focus to other attractive and suitable jurisdictions.

Burford Group Limited acts as Investment Adviser to the Company. www.burfordgroupltd.com

 

1 The Company reports "topline" total gross capital commitments (now in excess of $165 million) without deduction for realizations, subsequent participations or other changes, and also provides more detailed current portfolio information in this chart which is net of realizations, participations and other changes.

2 It should be noted that when Burford enters into agreements to fund international arbitration matters, one of its core areas of business, it typically does so using a form of agreement that commits the claimant to Burford irrevocably on agreed terms but provides a period of further case development during which Burford is free to withdraw unilaterally from the agreement with no penalty and usually without having expended any capital. This approach is desirable because it ensures that Burford does not expend undue time and resources on intensive diligence without being sure that it can fund the case on agreed terms once the diligence is completed. As a result, although the Company reports matters once definitive agreements have been signed, there remains the possibility that in some matters Burford will elect not to proceed in light of further information learned during the case development period. One matter, with a $4 million commitment, is presently in this case development period.

3 The special situations portfolio includes an investment made in October 2010 and reported in Burford's November 2010 portfolio update with a total commitment of $15 million. Burford subsequently sold a participation in that investment to a third party for $4 million and has thus reduced the capital commitment shown here accordingly.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEANKNAEAFEFF
Date   Source Headline
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding
26th Jun 20232:08 pmRNSUpdate & Release Date for 2Q23 Results
26th Jun 20232:07 pmRNSNotice of Early Redemption of Bonds due 2024
26th Jun 20232:05 pmRNSClosing of Private Offering of Senior Notes
23rd Jun 20237:00 amRNSPricing of Senior Notes Offering
22nd Jun 20235:22 pmRNSDirector/PDMR Shareholding
20th Jun 20231:00 pmRNSPrivate Offering of Senior Notes
13th Jun 202312:00 pmRNS1Q23 Results & Quarterly Report
8th Jun 20233:00 pmRNSNotice of 1Q23 Results & Results Call Details
6th Jun 202312:00 pmRNSNotice of Retail Shareholder Call on June 21, 2023
6th Jun 202312:00 pmRNSNotice of 2023 AGM
2nd Jun 202312:00 pmRNSSterling FX Rate for Second 2022 Interim Dividend
16th May 202312:00 pmRNSAvailability of 2022 Annual Report
16th May 202312:00 pmRNSAnnual results for year ended December 31, 2022
3rd May 20237:00 amRNSNotice of 2022 Results and Update on Accounting
3rd Apr 20237:30 amRNSRestoration - Burford Capital Limited
3rd Apr 20237:00 amRNSStatement on YPF Summary Judgment Ruling
31st Mar 20234:57 pmRNSSuspension - Burford Capital Limited
31st Mar 20234:14 pmRNSStatement re Petersen and Eton Park Matters
29th Mar 20233:00 pmRNSTransaction in Own Shares
22nd Mar 20234:00 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSUpdate on 2022 Business Activity
3rd Jan 202312:00 pmRNSUpdate on and Completion of Share Purchases by EBT
30th Dec 20221:13 pmRNSDirector/PDMR Shareholding
28th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
16th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
9th Dec 20225:00 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSIntended Share Purchases by Employee Benefit Trust
25th Nov 202212:00 pmRNSDirector/PDMR Bondholding
16th Nov 202212:00 pmRNSAppointment of Joint Corporate Broker
9th Nov 202212:00 pmRNSSterling FX Rate for 2022 Interim Dividend
1st Nov 20221:23 pmRNSBurford Capital Releases 2022 GC Survey Results
13th Sep 20223:27 pmRNSBurford Capital-Report on Class Action Recoveries
6th Sep 20227:00 amRNSJordan Licht Appointed Chief Financial Officer
26th Aug 20222:00 pmRNSDirector/PDMR Shareholding
24th Aug 20222:00 pmRNSDirector/PDMR Shareholding
16th Aug 20222:00 pmRNSPDMR Shareholding and Transaction in Own Shares
9th Aug 202212:01 pmRNSDr. Rukia Baruti Appointed as Board Director
9th Aug 202212:00 pmRNSInterim Results for six months ended 30 June 2022
26th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
26th Jul 202212:00 pmRNSNotice of 1H22 Results Date & Results Call Details
25th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
27th Jun 202211:30 amRNSDirector/PDMR Shareholding
15th Jun 20225:30 pmRNSPurchases of Shares for NED Plan and PDMR Notices
13th Jun 20227:00 amRNS$350 Million Post-Settlement Investment Fund Close

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.